2-methyl-thieno-benzodiazepine lyophilized formulation
A stable, amorphous, lyophilized, parenteral formulation comprises olanzapine as an active ingredient, tartaric acid as a solubilizer and lactose as a stabilizer. The formulation can be used for treating agitation which may be associated with psychotic disorders, schizophrenia, bipolar disorder, dem...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | A stable, amorphous, lyophilized, parenteral formulation comprises olanzapine as an active ingredient, tartaric acid as a solubilizer and lactose as a stabilizer. The formulation can be used for treating agitation which may be associated with psychotic disorders, schizophrenia, bipolar disorder, dementia or neurodegenerative disorders. |
|---|